AR090915A1 - Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg - Google Patents
Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de iggInfo
- Publication number
- AR090915A1 AR090915A1 ARP130101495A ARP130101495A AR090915A1 AR 090915 A1 AR090915 A1 AR 090915A1 AR P130101495 A ARP130101495 A AR P130101495A AR P130101495 A ARP130101495 A AR P130101495A AR 090915 A1 AR090915 A1 AR 090915A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- igg
- region
- linfopoyetina
- estromal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5418—IL-7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente solicitud provee proteínas de fusión de TSLP (proteína linfopoyetina estromal tímica) canina o sus fragmentos antigénicos, con la región Fc de un IgG, junto con ácidos nucleicos que codifican estas proteínas de fusión. Además revela métodos para la preparación y el uso de estas proteínas de fusión y ácidos nucleicos. También se divulgan vectores de expresión, productos farmacéuticos y método de tratamiento o prevención de síntomas alérgicos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261642563P | 2012-05-04 | 2012-05-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR090915A1 true AR090915A1 (es) | 2014-12-17 |
Family
ID=48325700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130101495A AR090915A1 (es) | 2012-05-04 | 2013-05-02 | Proteina de fusion de proteina linfopoyetina estromal timica canina con la region fc de igg |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR090915A1 (es) |
| WO (1) | WO2013164435A2 (es) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69836082T2 (de) | 1997-08-01 | 2007-05-10 | Schering Corp. | Membranproteine aus säugetierzellen; verwandte reagentien |
| ES2288036T5 (es) | 1998-11-13 | 2017-07-06 | Immunex Corporation | ADN de TSLP humano y polipéptidos |
| US6890734B2 (en) | 2000-11-10 | 2005-05-10 | Schering Corporation | Nucleic acids encoding a cytokine receptor complex |
| SE532251C2 (sv) | 2006-11-28 | 2009-11-24 | Theravac Pharmaceuticals Ab | Nya formuleringar av TSLP för behandling av TH2-medierade inflammatoriska sjukdomar genom vaccinering |
| UA95329C2 (ru) | 2006-12-14 | 2011-07-25 | Шеринг-Плау Лтд. | Собачий тимусный стромальный лимфопоэтин и его применение |
| EP2129690A1 (en) * | 2006-12-14 | 2009-12-09 | Schering Corporation | Engineered anti-tslp antibody |
| WO2011056772A1 (en) * | 2009-11-04 | 2011-05-12 | Schering Corporation | Engineered anti-tslp antibody |
-
2013
- 2013-05-02 AR ARP130101495A patent/AR090915A1/es unknown
- 2013-05-03 WO PCT/EP2013/059212 patent/WO2013164435A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013164435A2 (en) | 2013-11-07 |
| WO2013164435A3 (en) | 2013-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550205A1 (en) | IL-22 POLYPEPTIDES AND IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
| CO2019003945A2 (es) | Proteínas de fusión heterodiméricas biespecíficas que contienen proteínas de fusión fc il-15/il-15rα y fragmentos de anticuerpo pd-1 | |
| CY1125392T1 (el) | Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων | |
| CO2018002450A2 (es) | Proteínas de fusión de gitrl y usos de las mismas | |
| BR112018011073A2 (pt) | anticorpos antimiostatina, polipeptídeos contendo regiões fc variantes e métodos de utilização | |
| UY36889A (es) | Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas | |
| CR20180154A (es) | Moléculas de unión a linfopoyetina estromal timica (tslp) y métodos de uso de las moléculas | |
| BR112017008165A2 (pt) | anticorpos de domínio único direcionados contra antígenos intracelulares | |
| EA201990017A1 (ru) | Антитела к миостатину и способы их применения | |
| BR112017006178A2 (pt) | região fc, anticorpos, formulação farmacêutica e usos dos anticorpos | |
| BR112016014810A2 (pt) | Antagonistas de fcrn e métodos de uso | |
| BR112013027829A2 (pt) | anticorpos anti-cd40 e método de uso | |
| PE20210107A1 (es) | Anticuerpos anti-cd3 y metodos de uso | |
| BR112017001940A2 (pt) | proteínas de fusão de interleucina-2/receptor alfa de interleucina-2 e processos de uso | |
| EA202091166A1 (ru) | ПОЛИПЕПТИДЫ, СОДЕРЖАЩИЕ Fc С ИЗМЕНЕННЫМ ГЛИКОЗИЛИРОВАНИЕМ И СНИЖЕННОЙ ЭФФЕКТОРНОЙ ФУНКЦИЕЙ | |
| BR112016022841A8 (pt) | Anticorpo igm, iga, igg / igm ou igg / iga, ou um fragmento de ligação ao antígeno do mesmo, composição que o compreende e uso do mesmo | |
| CO6640254A2 (es) | Método para preparar anticuerpos con propiedades mejoradas | |
| BR112017006598A2 (pt) | anticorpo de repetições antidipeptídeo derivado de ser humano (dprs) | |
| EA201592285A1 (ru) | Антигенсвязывающие белки к рецептору онкостатина м | |
| BR112017023131A2 (pt) | anticorpos anti- fcrn | |
| EA202091239A1 (ru) | Слитый белок на основе терапевтического фермента, имеющий новую структуру, и его применение | |
| BR112016016737A2 (pt) | Peptídeos, dispositivos e métodos para detecção de anticorpos contra anaplasma | |
| EA202090084A1 (ru) | Новый терапевтический ферментный слитый белок и его применение | |
| BR112022011723A2 (pt) | Anticorpo anti-ctla-4 e uso do mesmo | |
| UY37752A (es) | Proteínas de unión al antígeno anti-jagged1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |